Patient Treatment Completed in Dental Implant Study
Filed with ASX · · 2 pages · English
Story so far
Earlier from Orthocell
- OCC Receives New Patents for Celgro Platform Technology
- Investor Update
- Orthocell Secures CelGro Patent Protection in Japan
- Successful CelGro Results Presented at Key Euro Conference
- Orthocell Receives A$2.5m R&D tax Incentive Refund
Later from Orthocell
- Share Placement Successfully Raises $1.8m
- CelGro Approved in Key UK Public Dental Hospital
- Orthocells Ortho-ATI shows 82% success rate
- Orthocell Submits AUS Regulatory Application for CelGro
- First Patients Complete Nerve Regeneration Trial
Follow Orthocell into a list and get an email when it puts out news.
Follow Orthocell